CQUniversity Researcher Working To Combat Cancer
CQUniversity's PhD student Emily Henkel, is working at the forefront of research into a rainforest-derived anti-cancer drug known as EBC-46.
Emily won a scholarship that enables her to undertake 10 weeks of industry experience with Professor Peter Parsons at the Queensland Institute of Medical Research. Emily’s work will help tailor the drug’s use with specific types of tumours.
She will gain skills on advanced instruments for chemical analysis while studying concentrations of EBC-46 and measuring the products of its metabolic reactions in solutions and cells.
The drug EBC-46 is being developed by biotech company QBiotics, who work to create pharmaceutical products that have the potential to address major health problems using ingredients sourced from Australia's tropical rainforests.
Research at CQUniversity has been classified as “well above world standard” in the area of “other Medical and Health Sciences” by recent Excellence in Research Australia (ERA) rankings.